The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts

被引:16
|
作者
Prottengeier, Johannes [1 ]
Koutsilieri, Eleni [2 ]
Scheller, Carsten [2 ]
机构
[1] Erlangen Univ Hosp, Dept Anesthesiol, D-91054 Erlangen, Germany
[2] Univ Wurzburg, Inst Immunol & Virol, D-97070 Wurzburg, Germany
来源
AIDS RESEARCH AND THERAPY | 2014年 / 11卷
关键词
HIV; Reactivation; Opioids; Heroine; Morphine; Naloxone; ACH-2; HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN PERIPHERAL-BLOOD; INJECTING DRUG-USERS; HOMOSEXUAL-MEN; DOCUMENTED DATES; CELL; EXPRESSION; MORPHINE; AIDS; PROGRESSION;
D O I
10.1186/1742-6405-11-17
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Opioids may have effects on susceptibility to HIV-infection, viral replication and disease progression. Injecting drug users (IDU), as well as anyone receiving opioids for anesthesia and analgesia may suffer the clinical consequences of such interactions. There is conflicting data between in vitro experiments showing an enhancing effect of opioids on HIV replication and clinical data, mostly showing no such effect. For clarification we studied the effects of the opioids heroin and morphine on HIV replication in cultured CD4-positive T cells at several concentrations and we related the observed effects with the relevant reached plasma concentrations found in IDUs. Methods: Latently-infected ACH-2 T lymphoblasts were incubated with different concentrations of morphine and heroine. Reactivation of HIV was assessed by intracellular staining of viral Gag p24 protein and subsequent flow cytometric quantification of p24-positive cells. The influence of the opioid antagonist naloxone and the antioxidants N-acetyl-cysteine (NAC) and glutathione (GSH) on HIV reactivation was determined. Cell viability was investigated by 7-AAD staining and flow cytometric quantification. Results: Morphine and heroine triggered reactivation of HIV replication in ACH-2 cells in a dose-dependent manner at concentrations above 1 mM (EC50 morphine 2.82 mM; EC50 morphine 1.96 mM). Naloxone did not interfere with heroine-mediated HIV reactivation, even at high concentrations (1 mM). Opioids also triggered necrotic cell death at similar concentrations at which HIV reactivation was observed. Both opioid-mediated reactivation of HIV and opioid-triggered cell death could be inhibited by the antioxidants GSH and NAC. Conclusions: Opioids reactivate HIV in vitro but at concentrations that are far above the plasma levels of analgesic regimes or drug concentrations found in IDUs. HIV reactivation was mediated by effects unrelated to opioid-receptor activation and was tightly linked to the cytotoxic activity of the substances at millimolar concentrations, suggesting that opioid-mediated reactivation of HIV was due to accompanying effects of cellular necrosis such as activation of reactive oxygen species and NF-kB.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] A Stochastic Model of Latently Infected Cell Reactivation and Viral Blip Generation in Treated HIV Patients
    Conway, Jessica M.
    Coombs, Daniel
    PLOS COMPUTATIONAL BIOLOGY, 2011, 7 (04)
  • [22] HIV-1 Reactivation Induced by Apicidin Involves Histone Modification in Latently Infected Cells
    Lin, Shiguan
    Zhang, Yuhao
    Ying, Hao
    Zhu, Huanzhang
    CURRENT HIV RESEARCH, 2011, 9 (04) : 202 - 208
  • [23] The Nurr1/CoREST Transrepression Pathway Impairs HIV Reactivation in Latently Infected Microglial Cells
    Alvarez, David
    Dobrowolsky, Curtis
    Karn, Jonathan
    JOURNAL OF NEUROVIROLOGY, 2012, 18 : 6 - 7
  • [24] CpG oligodeoxynucleotides activate HIV replication in latently infected human T cells
    Scheller, C
    Ullrich, A
    McPherson, K
    Hefele, B
    Knöferle, J
    Lamla, S
    Olbrich, ARM
    Stocker, H
    Arasteh, K
    ter Meulen, V
    Rethwilm, A
    Koutsilieri, E
    Dittmer, U
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) : 21897 - 21902
  • [25] Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells
    Walker-Sperling, Victoria E. K.
    Cohen, Valerie J.
    Tarwater, Patrick M.
    Blankson, Joel N.
    JOURNAL OF VIROLOGY, 2015, 89 (18) : 9631 - 9638
  • [26] Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell Line
    Liu, Ye
    Jeeninga, Rienk E.
    Klaver, Bep
    Berkhout, Ben
    Das, Atze T.
    VIRUSES-BASEL, 2021, 13 (12):
  • [27] PROPHYLACTIC ORAL ACYCLOVIR EFFECTIVELY REDUCES HERPES-SIMPLEX VIRUS-1 REACTIVATION FOLLOWING EXPOSURE OF LATENTLY-INFECTED MICE TO ULTRAVIOLET-B
    BLATT, AN
    BRADY, RH
    LAYCOCK, KA
    LEIB, DA
    MILLER, JK
    KROGSTAD, DJ
    PEPOSE, JS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 1134 - 1134
  • [28] Innate Immune Training Enhances the Reactivation of Latently Infected HIV-1 from Monocytic Cell lines
    James, Heera
    Forbes, Greta E.
    John, Sinu P.
    Fraser, Iain Dc
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [29] PURINOGENIC IMMUNODEFICIENCY DISEASES - DIFFERENTIAL EFFECTS OF DEOXYADENOSINE AND DEOXYGUANOSINE ON DNA-SYNTHESIS IN HUMAN T-LYMPHOBLASTS
    WILSON, JM
    MITCHELL, BS
    DADDONA, PE
    KELLEY, WN
    JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (05): : 1475 - 1484
  • [30] 4-phenylquinoline-8-amine induces HIV-1 reactivation and apoptosis in latently HIV-1 infected cells
    Kitamura, Haruki
    Sukegawa, Sayaka
    Matsuda, Kouki
    Tanimoto, Kousuke
    Kobayakawa, Takuya
    Takahashi, Kazuho
    Tamamura, Hirokazu
    Tsuchiya, Kiyoto
    Gatanaga, Hiroyuki
    Maeda, Kenji
    Takeuchi, Hiroaki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 641 : 139 - 147